Preclinical therapeutic evaluation of systemic chemotherapy regimens in combination with SHP2 inhibitor in NF1-associated malignant peripheral nerve sheath tumors

syn68747438

Created By NF Service nf-osi-service

grantDOI: https://doi.org/10.48105/ctf.2025-05-002.pc.gr.231762
studyName: Preclinical therapeutic evaluation of systemic chemotherapy regimens in combination with SHP2 inhibitor in NF1-associated malignant peripheral nerve sheath tumors
dataStatus: Data Pending
initiative: Drug Discovery Initiative
studyLeads: Lindy Zhang
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
grantEndDate: 1814313600000
institutions: Johns Hopkins University
fundingAgency: CTF
manifestation: MPNST
embargoEndDate: 1845936000000
grantStartDate: 1751328000000
studyFileviewId: syn68747445
syn68747439
syn68747548
syn68747440
syn68747445
syn68747441

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Preclinical therapeutic evaluation of systemic chemotherapy regimens in combination with SHP2 inhibitor in NF1-associated malignant peripheral nerve sheath tumors page is loading…

Preclinical therapeutic evaluation of systemic chemotherapy regimens in combination with SHP2 inhibitor in NF1-associated malignant peripheral nerve sheath tumors

syn68747438

Drop files to upload

Preclinical therapeutic evaluation of systemic chemotherapy regimens in combination with SHP2 inhibitor in NF1-associated malignant peripheral nerve sheath tumors page is loading…